Association of IL-1RN polymorphism with diabetes type 2 in Central Indian Population


  • Udita Singh Centre for Biotechnology Studies, A.P.S. University Rewa, Madhya Pradesh, India - 486001
  • Pallavi Indurkar Department of Medicine, Shyam Shah Medical College Rewa, Madhya Pradesh, India - 486001
  • Arti Saxena Department of Zoology, Govt. Science College Rewa, Madhya Pradesh, India - 486001
  • Pankaj Mishra School of Environmental Biology, A.P.S. University Rewa, Madhya Pradesh, India - 486001
  • Arvind K Tripathi Centre for Biotechnology Studies, A.P.S. University Rewa, Madhya Pradesh, India - 486001


The interleukin-1 receptor antagonist (IL-1RA) is a protein encoded by the IL1RN gene in human. In present study, anti-inflammatory gene; IL1RN has been studied for their association with diabetes type 2. A number of 190 diabetics and 210 healthy controls of central India were recruited for this study and anthropometric and lifestyle data were collected during sampling. Genetic polymorphism study of IL-1β gene was undertaken using PCR-RFLP, meanwhile IL-4 polymorphism was investigated using PCR-VNTR (Variable number of tandem repeats) analysis. Genotype, allele frequencies and carriage rates of IL-1β and IL-4 polymorphisms were recorded during this study. Diabetic patients had higher levels of fasting plasma glucose (P<0.0001), HbA1c (P<0.0001) and Post prandial glucose (P<0.0001) compared to control subjects. Nominal difference was observed for LDL-C (P=0.0462) and triglyceride (P=0.0024). Diabetic patients had higher levels of weight of women (P=0.0024), men (P=0.0157) and Body Mass Index (BMI) of women (P=0.0388), Waist Hip Ratio (WHR) in women (P<0.0001) and WHR in men (P=0.0147). Our findings suggested carriage of genotype I/II and II/II (p=0.0002; OR=2.194, 95% CI 1.455- 3.310 and p=0.0772; OR=1.80, 95% CI 0.9434- 3.434 respectively) were strongly associated with diabetes susceptibility.


Download data is not yet available.


Abate N, Chandalia M (2003) The impact of ethnicity on Type 2 diabetes. J Diabetes complication 17: 39-58

Achyut BR, Srivastava A, Bhattacharya S, Mittal B (2007) Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 377: 163-169

Arner P (2000) Obesity a genetic disease of adipose tissue? Br J Nutr 83: S9-S16

Bid HK, Konwar R, Agrawal CG, Banerjee M (2008) Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J Med Sci 62: 259-266

Blakemore AI, Cox A, Gonzalez AM, Maskil JK, Hughes ME, Wilson RM, Ward JD, Duff GW (1996) Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 97: 369 –374

Clau M Larsen, Faulenbench M, Vaag A, Volund A, Ehses A, Seifert B et al. (2007) Interleukin-1 receptor antagonist in type 2 diabetes mellitus. N. Eng. Jr of Med 356: 1517-1526

Hurme M, Santtila S (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1β genes. Eur J Immunol 28: 2598– 2602

Maedler K, Sergeev P, Ehses JA, Mathe Z, Bosco D, Berney T, Dayer JM, Reinecke M, Halban PA, Donath MY (2004) Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets. Proc Natl Acad Sci USA 101: 8138– 8143

Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, Hayden E, Huber K, Wagner O, Mannhalter C (2002) Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 51: 3582– 3585

McCarthy MI, Froguel P (2002) Genetic approaches to the molecular understanding of type 2 diabetes. Am J Physiol Endocrinol Metab 283: 217-225

Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nuc Acids Res 16 (3): 1215

Patel SK, Wong AL, Wong FL, Breen EC, Hurria A, Smith M, Kinjo C, Paz IB, Kruper L, Somlo G, Mortimer JE, Palomares MR, Irwin MR, Bhatia S (2015) Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women with Newly Diagnosed Breast Cancer. J Natl Cancer Inst 107 (8): 1-7

Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, Bandinelli S, Corsi AM, Guralnik JM, Ferruci L, Melzer D, Frayling TM (2007) Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun 8: 344– 351

Reiner AP, Wurfel MM, Lange LA, Carlson CS, Nord AS, Carty CL, Rieder MJ, Desmarais C, Jenny NS, Iribarren C, Walston JD, Williams OD, Nickerson DA, Jarvik GP (2008) Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol 28: 1407– 141

Strandberg L, Lorentzon M, Hellqvist A, Nilsson S, Wallenius V, Ohlsson C, Jansson JO (2006) Interleukin-1 system gene polymorphisms are associated with fat mass in young men. J Clin Endocr Metab 91: 2749-2754

Tarlow JK, Blakemore AI, Lennard A et al. (1993) Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91:403–4






Research Articles